ctrl-trade
All companies

JNJ vs MRK

Johnson & Johnson and Merck & Co., Inc., side by side.

On the numbers, JNJ leads most core categories in this snapshot.

JNJ is growing faster (revenue 9.9% vs 4.9%), runs a noticeably wider profit margin (21.8% net vs 13.6%), and trades somewhat cheaper on earnings (P/E 29.4x vs 35.3x). Both already trade close to their analyst price targets, so there's little easy upside priced in either way. MRK's case rests on a bigger dividend (2.6% vs 2.0%).

JNJ leads on

ValuationProfitabilityGrowthBalance sheetReturn on equity

MRK leads on

Dividend
Johnson & Johnson
JNJ Drug Manufacturers - General

Johnson & Johnson

Data as of July 2, 2026
View full JNJ profile →
Merck & Co., Inc.
MRK Drug Manufacturers - General

Merck & Co., Inc.

Data as of July 2, 2026
View full MRK profile →

Figures reflect each company's latest snapshot — no metric is a verdict on its own. New to these numbers? Learn how to read them →

Company Size

How large is this company relative to the overall market?

Metric JNJ MRK

Company Size

$611.38B · Mega-cap

$309.64B · Mega-cap

Valuation

Is this stock priced cheaply or expensively relative to its earnings and revenue?

Metric JNJ MRK

P/E Ratio

29.4x

35.3x

Forward P/E

20.0x

13.1x

Price-to-Sales

6.3x

4.7x

Profitability

How efficiently does the company turn revenue into profit?

Metric JNJ MRK

Profit Margin

21.8%

13.6%

Gross Margin

68.0%

76.7%

Return on Equity

26.4%

18.9%

Growth

Is the business expanding — or contracting?

Metric JNJ MRK

Revenue Growth

9.9%

4.9%

Earnings Growth

-52.9%

Financial Health

Can the company handle its debts and short-term obligations?

Metric JNJ MRK

Debt-to-Equity

0.68x

1.07x

Current Ratio

1.02x

1.30x

Dividends

Does the company pay shareholders regular cash income?

Metric JNJ MRK

Dividend Yield

2.0%

2.6%

Risk & Volatility

How much does this stock move relative to the overall market?

Metric JNJ MRK

Volatility (Beta)

0.26x

0.22x

Analyst View

What do professional Wall Street analysts say about this stock?

Metric JNJ MRK

Analyst Consensus

Buy (22 analysts)

Buy (27 analysts)

Analyst Target Price

$257.50

+1.4% vs price

$130.78

+4.3% vs price

This comparison is a factual summary of reported metrics, not a recommendation to buy, sell, or hold either stock. One company leading on a metric doesn't make it the better investment for you.

Early access

See the whole picture inside Ctrl-Trade

This page is a free preview. Inside the app, the full fundamentals overview sits right next to your positions — and you can run a complete comparison against any stock, or an entire industry, in a single view.

Not yet public — join the waitlist for early access. No spam.

Full fundamentals, right beside your trades
Compare any two stocks, head to head
Or stack a whole industry side by side